Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Casonato

Showing results (81-90 of 115) with videos related to

Pageof 12
Sort By:
La Ricerca in Clinica E in Laboratorio|January 1, 1979
[Factor XIII deficiency due to lack of both the S and A subunits. (Classification of factor XIII deficiency in 2 groups)]A Girolami, A Burul, M G Cappellato, et al.
Thrombosis and Haemostasis|March 4, 1999
Post-DDAVP thrombocytopenia in type 2B von Willebrand disease is not associated with platelet consumption: failure to demonstrate glycocalicin increase or platelet activationA Casonato, A Steffan, E Pontara, et al.
Acta Haematologica|January 1, 1984
Clinical significance of beta-thromboglobulin in patients with high platelet countF Fabris, M L Randi, A Casonato, et al.
European Journal of Clinical Investigation|April 1, 1983
Normal and low molecular weight heparins: interaction with human plateletsF Fabris, F Fussi, A Casonato, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 1, 1992
Impaired release of tissue plasminogen activator (t-PA) following DDAVP infusion in von Willebrand's disease with low platelet von Willebrand factor contentA Casonato, M T Sartori, E Pontara, et al.
Thrombosis and Haemostasis|September 1, 1996
Inhibitory effect of prostacyclin and nitroprusside on type IIB von Willebrand factor-promoted platelet activationM Francesconi, A Casonato, S Pagan, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 22, 2000
Do hemophilia A and von Willebrand disease protect against carotid atherosclerosis? A comparative study between coagulopathics and normal subjects by means of carotid echo-color Doppler scanF Bilora, C Dei Rossi, B Girolami, et al.
British Journal of Haematology|November 1, 1989
Platelet membrane abnormalities in myeloproliferative disorders: decrease in glycoproteins Ib and IIb/IIIa complex is associated with deficient receptor functionM Mazzucato, L De Marco, V De Angelis, et al.
Pediatric Nephrology (Berlin, Germany)|March 1, 1991
Effect of human recombinant erythropoietin on bleeding time, platelet number and function in children with end-stage renal disease maintained by haemodialysisF Fabris, I Cordiano, M L Randi, et al.
European Journal of Clinical Investigation|August 1, 1985
Effect of heparin and aspirin on platelet and clotting activation during leukapheresisF Fabris, A Casonato, M L Randi, et al.
Pageof 12

Showing results (81-90 of 115) with videos related to

Sort By:
Pageof 12
La Ricerca in Clinica E in Laboratorio|January 1, 1979
[Factor XIII deficiency due to lack of both the S and A subunits. (Classification of factor XIII deficiency in 2 groups)]A Girolami, A Burul, M G Cappellato, et al.
Thrombosis and Haemostasis|March 4, 1999
Post-DDAVP thrombocytopenia in type 2B von Willebrand disease is not associated with platelet consumption: failure to demonstrate glycocalicin increase or platelet activationA Casonato, A Steffan, E Pontara, et al.
Acta Haematologica|January 1, 1984
Clinical significance of beta-thromboglobulin in patients with high platelet countF Fabris, M L Randi, A Casonato, et al.
European Journal of Clinical Investigation|April 1, 1983
Normal and low molecular weight heparins: interaction with human plateletsF Fabris, F Fussi, A Casonato, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 1, 1992
Impaired release of tissue plasminogen activator (t-PA) following DDAVP infusion in von Willebrand's disease with low platelet von Willebrand factor contentA Casonato, M T Sartori, E Pontara, et al.
Thrombosis and Haemostasis|September 1, 1996
Inhibitory effect of prostacyclin and nitroprusside on type IIB von Willebrand factor-promoted platelet activationM Francesconi, A Casonato, S Pagan, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 22, 2000
Do hemophilia A and von Willebrand disease protect against carotid atherosclerosis? A comparative study between coagulopathics and normal subjects by means of carotid echo-color Doppler scanF Bilora, C Dei Rossi, B Girolami, et al.
British Journal of Haematology|November 1, 1989
Platelet membrane abnormalities in myeloproliferative disorders: decrease in glycoproteins Ib and IIb/IIIa complex is associated with deficient receptor functionM Mazzucato, L De Marco, V De Angelis, et al.
Pediatric Nephrology (Berlin, Germany)|March 1, 1991
Effect of human recombinant erythropoietin on bleeding time, platelet number and function in children with end-stage renal disease maintained by haemodialysisF Fabris, I Cordiano, M L Randi, et al.
European Journal of Clinical Investigation|August 1, 1985
Effect of heparin and aspirin on platelet and clotting activation during leukapheresisF Fabris, A Casonato, M L Randi, et al.
Pageof 12